Evolutionary Trajectories in Phytopharmaceutical Drug Development: From Ethnopharmacology to Polypharmacology

The development of drugs from plants (phytopharmaceuticals) has evolved from traditional use to a sophisticated, evidence-based scientific discipline. This review delineates the critical evolutionary pathway from ethnopharmacology—the study of traditional medicinal uses of plants—to the modern paradigm of polypharmacology, which involves multi-target therapies. While ethnopharmacology provides a time-tested foundation for drug discovery by identifying biologically active plant species, it often focuses on single-component isolation. However, the therapeutic efficacy of many plant extracts is attributable to the synergistic actions of multiple constituents acting on multiple biological targets, a concept central to polypharmacology. This paper reviews these complementary approaches, highlighting how traditional knowledge, when interrogated with modern analytical and pharmacological techniques, can lead to the development of novel multi-target phytopharmaceuticals. We discuss the methodologies involved, present key examples, and address the challenges and future perspectives in this integrative field.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-09-30
DOI
https://doi.org/10.5281/zenodo.17522569
Primary Topic
Berberine and alkaloids research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evolutionary Trajectories in Phytopharmaceutical Drug Development: From Ethnopharmacology to Polypharmacology

Zenodo (CERN European Organization for Nuclear Research)
Berberine and alkaloids research
article

Evolutionary Trajectories in Phytopharmaceutical Drug Development: From Ethnopharmacology to Polypharmacology

article en

Abstract

The development of drugs from plants (phytopharmaceuticals) has evolved from traditional use to a sophisticated, evidence-based scientific discipline. This review delineates the critical evolutionary pathway from ethnopharmacology—the study of traditional medicinal uses of plants—to the modern paradigm of polypharmacology, which involves multi-target therapies. While ethnopharmacology provides a time-tested foundation for drug discovery by identifying biologically active plant species, it often focuses on single-component isolation. However, the therapeutic efficacy of many plant extracts is attributable to the synergistic actions of multiple constituents acting on multiple biological targets, a concept central to polypharmacology. This paper reviews these complementary approaches, highlighting how traditional knowledge, when interrogated with modern analytical and pharmacological techniques, can lead to the development of novel multi-target phytopharmaceuticals. We discuss the methodologies involved, present key examples, and address the challenges and future perspectives in this integrative field.

Zenodo (CERN European Organization for Nuclear Research)
Software Training and Development Centre (IN)
Openalex Percentile: Top 37%
Berberine and alkaloids research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Evolutionary Trajectories in Phytopharmaceutical Drug Development: From Ethnopharmacology to Polypharmacology · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS